Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35677172)

  • 1. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort.
    Van Dao T; Diep TB; Le Phuong T; Huggenberger R; Kumar A
    Front Oncol; 2022; 12():842296. PubMed ID: 35677172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study.
    Jazieh AR; Onal HC; Tan DSW; Soo RA; Prabhash K; Kumar A; Huggenberger R; Robb S; Cho BC
    J Thorac Oncol; 2021 Oct; 16(10):1733-1744. PubMed ID: 34051381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.
    Prabhash K; Tan DSW; Soo RA; Sitthideatphaiboon P; Chen YM; Voon PJ; Syahruddin E; Chu S; Huggenberger R; Cho BC
    Front Oncol; 2023; 13():1117348. PubMed ID: 37051534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world KINDLE-Latin America subset data on treatment patterns and clinical outcomes in patients with stage III non-small-cell lung cancer.
    Martin CM; Puello-Guerrero A; Mas-Lopez LA; Campos-Gómez S; Orlando-Orlandi FJ; Tejado Gallegos LF; Huggenberger R
    Cancer Med; 2023 Jan; 12(2):1247-1259. PubMed ID: 35789068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohort.
    Aboelhassan R; Sobeih ME; El-Din MA; Ghali RR; El-Din IS; Khorshid O; Mokhtar M; Rabea AM; Belal A; Azim HA; Abdullah M; Elnahas T; Tawfik H; Abdelwahab S; Elsaid AA; Hashem T; Mancy M; Farag H
    Ther Adv Med Oncol; 2023; 15():17588359231212182. PubMed ID: 38028146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
    Lee J; Ahn HK; Kim SW; Han JY; Lee SS; Park HS; Lee HW; Kim JH; Cho E; Huggenberger R; Cho BC
    Cancer Med; 2024 Apr; 13(7):e7174. PubMed ID: 38622869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa - KINDLE Study.
    Jazieh AR; Sağlam EK; Önal HC; Abdelkader Y; Gaafar R; Dawoud E; Nassar M; Alshorbagy D; El Ashry H; Elsayed M
    Clin Lung Cancer; 2022 Jun; 23(4):364-373. PubMed ID: 35277345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
    Provencio M; Carcereny E; López Castro R; Calvo V; Rodríguez Abreu D; Cobo M; Ortega AL; Bernabé R; Guirado M; Massutí B; Del Barco-Morillo E; Bosch-Barrera J; Camps C; Carroll R; Rault C; Chaib C; Penrod J; Vo L; Ralphs E; Daumont MJ
    Transl Lung Cancer Res; 2023 Oct; 12(10):2113-2128. PubMed ID: 38025806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.
    Ferro A; Sepulcri M; Schiavon M; Scagliori E; Mancin E; Lunardi F; Gennaro G; Frega S; Dal Maso A; Bonanno L; Paronetto C; Caumo F; Calabrese F; Rea F; Guarneri V; Pasello G
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study.
    Su PL; Chang GC; Hsiao SH; Hsia TC; Lin MC; Lin MH; Shih JY; Yang CT; Yang SH; Chen YM
    JTO Clin Res Rep; 2022 Mar; 3(3):100292. PubMed ID: 35252898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: Expanded cohort of the SOLUTION study.
    Murakami H; Horinouchi H; Harada H; Sobue T; Kato T; Atagi S; Kozuki T; Tokito T; Oizumi S; Seike M; Ohashi K; Mio T; Sone T; Jinushi M; Tsuboi M
    Lung Cancer; 2022 Mar; 165():152-163. PubMed ID: 35144145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
    Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
    Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
    Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of surgery for stage IIIa non-small cell lung cancer].
    Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
    Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.
    Konert T; Vogel WV; Paez D; Polo A; Fidarova E; Carvalho H; Duarte PS; Zuliani AC; Santos AO; Altuhhova D; Karusoo L; Kapoor R; Sood A; Khader J; Al-Ibraheem A; Numair Y; Abubaker S; Soydal C; Kütük T; Le TA; Canh NX; Bieu BQ; Ha LN; Belderbos JSA; MacManus MP; Thorwarth D; Hanna GG
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2235-2243. PubMed ID: 31367906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
    Cicenas S; Zaliene A; Atkocius V
    Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced stage III non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow up.
    Abbas MN; Ayoola A; Padman S; Kumar R; Leung J; Ullah S; Koczwara B; Sukumaran S; Kichenadasse G; Roy A; Richards AM; Bowden JJ; Karapetis CS
    J Thorac Dis; 2019 Oct; 11(10):4241-4248. PubMed ID: 31737309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage III Non-Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort.
    Cordeiro de Lima VC; Baldotto CS; Barrios CH; Sobrinho EM; Zukin M; Mathias C; Zaffaroni F; Nery RC; Madeira G; Amadio AV; Coelho JC; Geib G; Simões MF; Castro G
    J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.